Biotalys NV
3.5000
12-March-25 04:49:56
15 minutes delayed
Stocks
-0.1200
-3.31%
Today's range
3.5000 - 3.5000
ISIN
BE0974386188
Source
Cboe
-
Information on the total number of voting rights and shares
03 Jan 2023 12:00:00 By Nasdaq GlobeNewswire
-
Results of the Extraordinary Shareholders’ Meeting
27 Dec 2022 12:00:00 By Nasdaq GlobeNewswire
-
Biotalys Creates Scientific Advisory Committee with Leading Experts
01 Dec 2022 01:00:00 By Nasdaq GlobeNewswire
-
Invitation to an Extraordinary Shareholders’ Meeting
25 Nov 2022 01:00:00 By Nasdaq GlobeNewswire
-
Biotalys announces participation at investor and industry events for the remainder of 2022
07 Nov 2022 01:00:00 By Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
31 Oct 2022 13:00:00 By Nasdaq GlobeNewswire
-
Biotalys and Novozymes announce successful Evoca™ feasibility study
24 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
Biotalys announces participation at investor and industry events for the upcoming months
13 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
Biotalys Reports Half-Year 2022 Financial Results and Business Highlights
19 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
29 Jul 2022 12:00:00 By Nasdaq GlobeNewswire
-
Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca™
21 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
Biotalys’ First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product
25 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
Latest Field Trials Validate Strength of Biotalys’ First Biocontrol Evoca
19 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
Biotalys Obtains New Fungicide Resistance Class for its First Biofungicide
03 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
29 Apr 2022 12:00:00 By Nasdaq GlobeNewswire
-
Biotalys Appoints Michiel van Lookeren Campagne to Board of Directors
19 Apr 2022 01:00:00 By Nasdaq GlobeNewswire
-
Results of the Annual and Extraordinary Shareholders’ Meetings
15 Apr 2022 12:00:00 By Nasdaq GlobeNewswire
-
Biotalys Appoints Carlo Boutton as Chief Scientific Officer
31 Mar 2022 01:00:00 By Nasdaq GlobeNewswire
-
Invitation to the Annual and Extraordinary Shareholders’ Meetings
15 Mar 2022 02:00:00 By Nasdaq GlobeNewswire
-
Biotalys Reports Full Year 2021 Financial Results and Business Highlights
11 Mar 2022 01:00:00 By Nasdaq GlobeNewswire